Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Cole Eye Institute - Cleveland Clinic Foundation
mi
from
Cleveland, OH
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cole Eye Institute - Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Oregon Retina
mi
from
Eugene, OR
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Oregon Retina
mi
from
Eugene, OR
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Retina Specialists, P.C.
mi
from
Camp Hill, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retina Specialists, P.C.
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Mid Atlantic Retina- Wills Eye Institute
mi
from
Philadelphia, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Mid Atlantic Retina- Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Eye Center
mi
from
Pittsburgh, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Eye Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Associates in Ophthalmology
mi
from
West Mifflin, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmology
mi
from
West Mifflin, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Research Institute of Texas, LLC
mi
from
Abilene, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Research Institute of Texas, LLC
mi
from
Abilene, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Brian B. Berger, MD and Associates / Retina Research Center
mi
from
Austin, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Brian B. Berger, MD and Associates / Retina Research Center
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wagner Macula and Retina Center
mi
from
Virginia Beach, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wagner Macula and Retina Center
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Macula and Retina Institute
mi
from
Glendale, CA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Macula and Retina Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants, San Diego
mi
from
Poway, CA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Associates of Florida
mi
from
Saint Petersburg, FL
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates of Florida
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Harvard Vanguard Medical Associates
mi
from
Boston, MA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Harvard Vanguard Medical Associates
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Delaware Valley Retina Associates
mi
from
Lawrenceville, NJ
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Delaware Valley Retina Associates
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Northfield, NJ
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal and Ophthalmic Consultants
mi
from
Northfield, NJ
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
New York Eye & Ear
mi
from
New York, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
New York Eye & Ear
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of South Texas
mi
from
San Antonio, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Virginia Retina Center
mi
from
Warrenton, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Virginia Retina Center
mi
from
Warrenton, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Cosultants
mi
from
Charleston, WV
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Cosultants
mi
from
Charleston, WV
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
George Washington University
mi
from
Washington,
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Chicago Cornea Consultants, LTD
mi
from
Hoffman Estates, IL
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Chicago Cornea Consultants, LTD
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Jackson Eye
mi
from
Lake Villa, IL
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Jackson Eye
mi
from
Lake Villa, IL
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Charles River Eye Associates
mi
from
Winchester, MA
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Charles River Eye Associates
mi
from
Winchester, MA
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Associated Eye Care
mi
from
Stillwater, MN
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Associated Eye Care
mi
from
Stillwater, MN
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Consultants Ltd
mi
from
Saint Louis, MO
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Consultants Ltd
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
The May Eye Care Center
mi
from
Hanover, PA
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
The May Eye Care Center
mi
from
Hanover, PA
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Carolina Eyecare Physicians, LLC
mi
from
Mount Pleasant, SC
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Carolina Eyecare Physicians, LLC
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Duke Eye Center
mi
from
Durham, NC
Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Duke Eye Center
mi
from
Durham, NC
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University, Casey Eye Institute
mi
from
Portland, OR
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University, Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Royal Victorian Eye and Ear Hospital
mi
from
Melbourne,
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Royal Victorian Eye and Ear Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Francis I. Proctor Foundation
mi
from
San Francisco, CA
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Francis I. Proctor Foundation
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gevokizumab for Active Scleritis
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gevokizumab for Active Scleritis
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Nitisinone for Type 1B Oculocutaneous Albinism
A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Nitisinone for Type 1B Oculocutaneous Albinism
A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Toyos Clinic
mi
from
Nashville, TN
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Toyos Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Toric Eye Strain and Stability Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Toric Eye Strain and Stability Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Advanced Vision Care
mi
from
Los Angeles, CA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Advanced Vision Care
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Jules Stein Eye Institute
mi
from
Los Angeles, CA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Jules Stein Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Eye Consultants of Atlanta
mi
from
Atlanta, GA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Eye Consultants of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Minnesota Eye Consultants
mi
from
Bloomington, MN
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Minnesota Eye Consultants
mi
from
Bloomington, MN
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
The Mackool Eye Institute
mi
from
Astoria, NY
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
The Mackool Eye Institute
mi
from
Astoria, NY
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Rosenthal Eye Surgery
mi
from
Great Neck, NY
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Rosenthal Eye Surgery
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Oregon Eye Associates
mi
from
Eugene, OR
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Oregon Eye Associates
mi
from
Eugene, OR
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Alkek Eye Center/ Baylor College of Medicine
mi
from
Houston, TX
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Alkek Eye Center/ Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
The Eye Institute of Utah
mi
from
Salt Lake City, UT
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
The Eye Institute of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials